FI85023B - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara berbanderivat. - Google Patents
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara berbanderivat. Download PDFInfo
- Publication number
- FI85023B FI85023B FI862174A FI862174A FI85023B FI 85023 B FI85023 B FI 85023B FI 862174 A FI862174 A FI 862174A FI 862174 A FI862174 A FI 862174A FI 85023 B FI85023 B FI 85023B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- sup
- sub
- process according
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Emergency Protection Circuit Devices (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Train Traffic Observation, Control, And Security (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Claims (8)
1. Förfarande för framställning av nya terapeu-tiskt användbara racemiska och optiskt aktiva berbanderi-5 vat med formeln I och salter därav, "rr^ »2/T)f"La „Λΐ & 1 2 15. vilken formal R och R betecknar oberoende av varandra hydroxyl, rakkedjad eller förgrenad alkoxi med 1-6 kol-1 2 atomer eller R och R bildar tillsammans en C^^-alky- lendioxigrupp; 3 4 R och R betecknar oberoende av varandra väte, rakkedjad 20 eller förgrenad alkyl med 1-4 kolatomer och som kan vara substituerad med hydroxyl; eller Cj^-alkoxikarbonyl eller cyan; och 5 R är väte eller C^_g-alifatisk acyl, känneteck-n a t därav, att oxogruppen i en racemlsk eller optiskt 25 aktiv förening med formeln :xci
30 H Ί,Π (II> o 12 3 4 35 där R , R , R och R betecknar samma som ovan, reduce- 30 8 5 023 ras, varefter, om sä önskas, den erhällna föreningen med 12 3 4 formeln I, där R , R , R och R betecknar sanuna som ovan 5 och R är väte, alkyleras, acyleras eller hydroxyleras, 12 3 varvid erhälls en förenlng med formeln I, där R , R , R 4 5 5 och R betecknar samma som ovan och R betecknar samma som ovan förutom väte, och, om sä önskas, transesterifie-ras den erhällna föreningen med formeln I eller uppdelas densamma i sina optiska isomerer eller omvandlas en före-ning med formeln I till ett salt eller omvandlas ett salt 10 till en fri förening med formeln I.
2. Förfarande enligt patentkravet 1, känne-t e c k n a t därav, att som reduktionsmedel används en metallhydrid.
3. Förfarande enligt patentkravet 1, känne-15 tecknat därav, att som reduktionsmedel används ett svavelhaltigt medel.
4. Förfarande enligt patentkravet 1, känne-tecknat därav, att reduktionen utförs genom an-vändning av väte i närvaro av en katalysator. 20 5. Förfarande enligt patentkravet 4, känne- tecknat därav, att som katalysator används Raney-nickel.
6. Förfarande enligt patentkravet 1, känne-tecknat därav, att som reduktionsmedel används ett 25 system bestäende av en alkohol och en alkalimetall.
7. Förfarande enligt patentkravet 1, känne-tecknat därav, att som utgängsämne används en op-tiskt aktiv förening med formeln (II).
8. Förfarande enligt patentkravet 1, känne-30 tecknat därav, att som acylerande medel används en acylhalogenid.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU851982A HU195505B (en) | 1985-05-24 | 1985-05-24 | Process for producing 7,8-methylendioxy-14-hydroxy-berban derivatives and pharmaceuticals comprising the same |
| HU198285 | 1985-05-24 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI862174A0 FI862174A0 (fi) | 1986-05-23 |
| FI862174A FI862174A (fi) | 1986-11-25 |
| FI85023B true FI85023B (fi) | 1991-11-15 |
| FI85023C FI85023C (sv) | 1992-02-25 |
Family
ID=10957145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI862174A FI85023C (sv) | 1985-05-24 | 1986-05-23 | Förfarande för framställning av nya terapeutiskt användbara berbanderi vat |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4851416A (sv) |
| EP (1) | EP0202950B1 (sv) |
| JP (1) | JPS61280492A (sv) |
| KR (1) | KR870001742B1 (sv) |
| CN (1) | CN1010779B (sv) |
| AT (1) | ATE95180T1 (sv) |
| AU (1) | AU599030B2 (sv) |
| CA (1) | CA1294964C (sv) |
| CS (1) | CS266586B2 (sv) |
| DD (1) | DD251289A5 (sv) |
| DE (1) | DE3689080T2 (sv) |
| DK (1) | DK242886A (sv) |
| ES (1) | ES8800938A1 (sv) |
| FI (1) | FI85023C (sv) |
| GR (1) | GR861348B (sv) |
| HU (1) | HU195505B (sv) |
| IE (1) | IE60479B1 (sv) |
| IL (1) | IL78722A (sv) |
| NO (1) | NO164098C (sv) |
| NZ (1) | NZ216280A (sv) |
| PH (1) | PH24053A (sv) |
| PL (1) | PL148617B1 (sv) |
| PT (1) | PT82634B (sv) |
| SU (2) | SU1508958A3 (sv) |
| YU (1) | YU46956B (sv) |
| ZA (1) | ZA863869B (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5122504A (en) * | 1990-02-27 | 1992-06-16 | The Board Of Trustees Of The Leland Stanford Junior University | Superconducting ribbon process using laser heating |
| WO1992020678A1 (en) * | 1991-05-22 | 1992-11-26 | Chinoin Gyógyszer- És Vegyészeti Gyár R.T. | New berbane derivatives, pharmaceutical compositions containing these compounds and process for the preparation of same |
| US5492907A (en) * | 1992-12-09 | 1996-02-20 | The United States Of America As Represented By The Department Of Health & Human Services | Antipsychotic composition and method of treatment |
| US5663167A (en) * | 1992-12-09 | 1997-09-02 | The United States Of America As Represented By The Department Of Health And Human Services | Antipsychotic composition and method of treatment |
-
1985
- 1985-05-24 HU HU851982A patent/HU195505B/hu unknown
-
1986
- 1986-05-08 IL IL78722A patent/IL78722A/xx not_active IP Right Cessation
- 1986-05-21 YU YU84886A patent/YU46956B/sh unknown
- 1986-05-21 JP JP61114973A patent/JPS61280492A/ja active Pending
- 1986-05-22 ES ES555206A patent/ES8800938A1/es not_active Expired
- 1986-05-23 GR GR861348A patent/GR861348B/el unknown
- 1986-05-23 IE IE137386A patent/IE60479B1/en not_active IP Right Cessation
- 1986-05-23 SU SU864027562A patent/SU1508958A3/ru active
- 1986-05-23 EP EP86303947A patent/EP0202950B1/en not_active Expired - Lifetime
- 1986-05-23 NZ NZ216280A patent/NZ216280A/xx unknown
- 1986-05-23 FI FI862174A patent/FI85023C/sv not_active IP Right Cessation
- 1986-05-23 PT PT82634A patent/PT82634B/pt not_active IP Right Cessation
- 1986-05-23 DE DE86303947T patent/DE3689080T2/de not_active Expired - Fee Related
- 1986-05-23 PL PL1986259689A patent/PL148617B1/pl unknown
- 1986-05-23 DK DK242886A patent/DK242886A/da not_active Application Discontinuation
- 1986-05-23 CA CA000509814A patent/CA1294964C/en not_active Expired - Lifetime
- 1986-05-23 NO NO862054A patent/NO164098C/no unknown
- 1986-05-23 PH PH33811A patent/PH24053A/en unknown
- 1986-05-23 CS CS863767A patent/CS266586B2/cs unknown
- 1986-05-23 DD DD86290542A patent/DD251289A5/de not_active IP Right Cessation
- 1986-05-23 KR KR1019860004054A patent/KR870001742B1/ko not_active IP Right Cessation
- 1986-05-23 AU AU57853/86A patent/AU599030B2/en not_active Ceased
- 1986-05-23 AT AT86303947T patent/ATE95180T1/de not_active IP Right Cessation
- 1986-05-23 CN CN85104693A patent/CN1010779B/zh not_active Expired
- 1986-05-23 ZA ZA863869A patent/ZA863869B/xx unknown
- 1986-05-23 US US06/867,323 patent/US4851416A/en not_active Expired - Fee Related
- 1986-09-29 SU SU864028190A patent/SU1573021A1/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100225702B1 (ko) | 인돌 유도체 | |
| US4810699A (en) | Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them | |
| HU198016B (en) | Process for producing benzene-condensed cycloalkan- and oxacycloalkan-trans-1,2-diamin derivatives and pharmaceutical compositions containing them | |
| HRP930508A2 (en) | Difenilpropilamina process for the preparation of the novel enylpropylamine derivatives | |
| FI85023B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara berbanderivat. | |
| NZ195504A (en) | Indolobenzoxazine derivatives and pharmaceutical compositions | |
| US4851429A (en) | Pharmaceutically useful tricyclic amines derived from 2,3,5,6,7,8-hexahydronaphtho(2,3-B)furan and from 2,3,6,7,8,9-hexahydro-5H-benzocyclohepta(2,3-B)furan | |
| FR2801310A1 (fr) | NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT | |
| IE850939L (en) | Oxazine dopamine agonists | |
| CS199610B2 (en) | Process for preparing 8-8-disubstituted 6-methylergolines and derivatives thereof | |
| JP2016516814A (ja) | コンブレタスタチン類似体 | |
| SU1017170A3 (ru) | Способ получени производных 3-амино-1-бензоксепина или их стереоизомеров, или их солей | |
| FI86301C (sv) | Förfarande för framställning av farmaceutiskt användbara naftoxaziner | |
| AU2004236227A1 (en) | Quinoline 3-amino chroman derivatives | |
| US4235903A (en) | 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use | |
| JP4308156B2 (ja) | 新規なベンゾ［ｂ］クロメノ−ナフチリジン−７−オン及びピラノ［２′，３′：７，８］キノ［２，３−ｂ］キノキサリン−７−オン化合物、それらの製法並びにそれらを含む医薬組成物 | |
| EP0162592B1 (en) | Heterocyclic amino compounds | |
| EA003361B1 (ru) | НОВЫЕ СОЕДИНЕНИЯ 7-ОКСО-2,3,7,14-ТЕТРАГИДРО-1H-БЕНЗО[b]-ПИРАНО[3,2-h]АКРИДИНКАРБОКСИЛАТА И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
| JP2005041864A (ja) | 新規ベンゾ〔ａ〕ピラノ〔３，２−ｈ〕アクリジン−７−オン化合物、その調製方法、およびそれらを含む医薬組成物 | |
| US5137908A (en) | 4-azahexacyclododecane compounds | |
| AU781768B2 (en) | New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| NO973442L (no) | Nye bismidforbindelser, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger inneholdende slike | |
| EP0036773B1 (en) | 2,3-dihydrobenzofurans, process for their preparation and pharmaceutical compositions containing them | |
| FI74961B (fi) | Foerfarande foer framstaellning av saosom psykofarmaka anvaendbara 4-metoximetylsubstituerade -karbolin-3-karboxylsyraderivat. | |
| US4122175A (en) | Morpholine containing benzimidazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: CHINOIN GYOGUSZER ES VEGYESZETI TERMEKEK |